Molly S. Crowe

790 total citations
13 papers, 607 citations indexed

About

Molly S. Crowe is a scholar working on Pharmacology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Molly S. Crowe has authored 13 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 5 papers in Molecular Biology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Molly S. Crowe's work include Cannabis and Cannabinoid Research (7 papers), Neuroscience and Neuropharmacology Research (4 papers) and Pharmacological Receptor Mechanisms and Effects (4 papers). Molly S. Crowe is often cited by papers focused on Cannabis and Cannabinoid Research (7 papers), Neuroscience and Neuropharmacology Research (4 papers) and Pharmacological Receptor Mechanisms and Effects (4 papers). Molly S. Crowe collaborates with scholars based in United States, Canada and United Kingdom. Molly S. Crowe's co-authors include Steven G. Kinsey, Aron H. Lichtman, Sudeshna Ghosh, Bogna M. Ignatowska‐Jankowska, Sara R. Nass, Jenny L. Wiley, Rae R. Matsumoto, Kelan Thomas, John Z. Cavendish and Linda Nguyen and has published in prestigious journals such as Gastroenterology, British Journal of Pharmacology and Pharmacology & Therapeutics.

In The Last Decade

Molly S. Crowe

13 papers receiving 600 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Molly S. Crowe United States	11	388	218	170	111	72	13	607
M.L. Latif United Kingdom	10	284 0.7×	129 0.6×	158 0.9×	122 1.1×	47 0.7×	20	622
Lee Koetzner United States	14	259 0.7×	272 1.2×	203 1.2×	185 1.7×	57 0.8×	25	630
Rafael Rivas‐Santisteban Spain	16	371 1.0×	273 1.3×	227 1.3×	65 0.6×	52 0.7×	39	737
Kent‐Olov Jonsson Sweden	10	625 1.6×	211 1.0×	137 0.8×	75 0.7×	99 1.4×	10	743
D. Matthew Walentiny United States	14	519 1.3×	410 1.9×	159 0.9×	148 1.3×	85 1.2×	29	755
Diana Coppola Italy	5	509 1.3×	107 0.5×	142 0.8×	92 0.8×	61 0.8×	7	726
Chanté Muller United States	4	356 0.9×	145 0.7×	61 0.4×	62 0.6×	35 0.5×	5	476
Sherry Shu‐Jung Hu Taiwan	16	727 1.9×	339 1.6×	185 1.1×	135 1.2×	91 1.3×	22	972
Elizabeth A. Cairns Australia	15	495 1.3×	206 0.9×	108 0.6×	33 0.3×	34 0.5×	29	634
M. G. Cascio United Kingdom	6	600 1.5×	258 1.2×	71 0.4×	47 0.4×	46 0.6×	9	702

Countries citing papers authored by Molly S. Crowe

Since Specialization

Citations

This map shows the geographic impact of Molly S. Crowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Molly S. Crowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Molly S. Crowe more than expected).

Fields of papers citing papers by Molly S. Crowe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Molly S. Crowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Molly S. Crowe. The network helps show where Molly S. Crowe may publish in the future.

Co-authorship network of co-authors of Molly S. Crowe

This figure shows the co-authorship network connecting the top 25 collaborators of Molly S. Crowe. A scholar is included among the top collaborators of Molly S. Crowe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Molly S. Crowe. Molly S. Crowe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Crowe, Molly S., Hongxia Wang, Bryan A. Blakeney, et al.. (2019). Expression and function of umami receptors T1R1/T1R3 in gastric smooth muscle. Neurogastroenterology & Motility. 32(2). e13737–e13737. 9 indexed citations

Nass, Sara R., et al.. (2018). Novel behavioral assays of spontaneous and precipitated THC withdrawal in mice. Drug and Alcohol Dependence. 191. 14–24. 26 indexed citations

Crowe, Molly S., Bryan A. Blakeney, Sunila Mahavadi, et al.. (2018). Identification of expression and function of the glucagon-like peptide-1 receptor in colonic smooth muscle. Peptides. 112. 48–55. 20 indexed citations

Blakeney, Bryan A., Molly S. Crowe, Sunila Mahavadi, Karnam S. Murthy, & John R. Grider. (2018). Branched Short-Chain Fatty Acid Isovaleric Acid Causes Colonic Smooth Muscle Relaxation via cAMP/PKA Pathway. Digestive Diseases and Sciences. 64(5). 1171–1181. 50 indexed citations

Crowe, Molly S., Sunila Mahavadi, Bryan A. Blakeney, Karnam S. Murthy, & John R. Grider. (2018). Su1667 - Expression and Function of Umami (T1R1/T1R3) and Sweet (T1R2/T1R3) Nutrient Receptors in Mouse Gastric Smooth Muscle. Gastroenterology. 154(6). S–568. 1 indexed citations

Crowe, Molly S. & Steven G. Kinsey. (2017). MAGL inhibition modulates gastric secretion and motility following NSAID exposure in mice. European Journal of Pharmacology. 807. 198–204. 13 indexed citations

Crowe, Molly S., Emma Leishman, Paul L. Prather, et al.. (2017). The monoacylglycerol lipase inhibitor KML29 with gabapentin synergistically produces analgesia in mice. British Journal of Pharmacology. 174(23). 4523–4539. 17 indexed citations

Nguyen, Linda, Kelan Thomas, Brandon Lucke‐Wold, et al.. (2016). Dextromethorphan: An update on its utility for neurological and neuropsychiatric disorders. Pharmacology & Therapeutics. 159. 1–22. 99 indexed citations

Wilkerson, Jenny L., Sudeshna Ghosh, Deniz Bağdaş, et al.. (2016). Diacylglycerol lipase β inhibition reverses nociceptive behaviour in mouse models of inflammatory and neuropathic pain. British Journal of Pharmacology. 173(10). 1678–1692. 40 indexed citations

10.

Ignatowska‐Jankowska, Bogna M., Gemma L. Baillie, Steven G. Kinsey, et al.. (2015). A Cannabinoid CB1 Receptor-Positive Allosteric Modulator Reduces Neuropathic Pain in the Mouse with No Psychoactive Effects. Neuropsychopharmacology. 40(13). 2948–2959. 138 indexed citations

11.

Crowe, Molly S., Emma Leishman, Matthew L. Banks, et al.. (2014). Combined inhibition of monoacylglycerol lipase and cyclooxygenases synergistically reduces neuropathic pain in mice. British Journal of Pharmacology. 172(7). 1700–1712. 32 indexed citations

12.

Crowe, Molly S., et al.. (2014). The endocannabinoid system modulates stress, emotionality, and inflammation. Brain Behavior and Immunity. 42. 1–5. 59 indexed citations

13.

Ignatowska‐Jankowska, Bogna M., Sudeshna Ghosh, Molly S. Crowe, et al.. (2013). In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects. British Journal of Pharmacology. 171(6). 1392–1407. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact